# Motor Function in the Setting of Nerve Allografts: Is This the Future of Facial Nerve Reconstruction?

## TL;DR

Processed nerve allografts may offer a promising alternative to autografts for facial nerve reconstruction, but more research is needed to confirm their effectiveness in complex cases.

## Contribution

This paper reviews current evidence on processed nerve allografts for motor nerve repair, highlighting their potential and limitations in facial nerve reconstruction.

## Key findings

- Processed nerve allografts show up to 85% recovery in nerve gaps under 50 mm.
- Outcomes decline in longer gaps and complex facial nerve repairs due to limited evidence.
- Registry data supports allograft use but lacks randomization and consistency.

## Abstract

Background: Peripheral nerve injuries, especially involving the facial nerve, present unique reconstructive challenges due to their complex functional demands and limited regenerative potential. While autografts remain the gold standard, their drawbacks—such as donor-site morbidity and limited availability—have driven interest in processed nerve allografts. Acellular grafts, in particular, offer promising off-the-shelf alternatives without the need for immunosuppression. Methods: We conducted a narrative review of the literature (1990–2023), identifying 55 peer-reviewed studies via PubMed, Embase, and Cochrane Library. The studies included clinical and preclinical work on motor nerve regeneration using processed nerve allografts, with particular attention to outcomes in facial nerve repair. Two independent reviewers conducted abstract screening, full-text review, and data extraction. Results: Processed nerve allografts show encouraging motor recovery in gaps under 50 mm, with recovery rates of up to 85% reported. Outcomes decrease significantly in longer gaps (>50–60 mm) and in complex cases, including facial nerve repairs, where evidence remains sparse and largely extrapolated from broader motor nerve data. Registry data (e.g., RANGER) support their use but are limited by heterogeneity and lack of randomization. Conclusions: Processed nerve allografts represent a viable alternative to autografts in selected cases—especially short to mid-length motor nerve defects. However, their role in facial nerve reconstruction remains insufficiently studied. Further trials are needed to address specific anatomical and functional challenges in this subgroup and to clarify long-gap efficacy.